Contact Hours: 1.0

Max CEU Credits: 0.1

Learning Objectives:

On completion of the chapter, the reader will be able to
1. Explain the role of the Philadelphia chromosome in the pathophysiology of chronic myelogenous leukemia (CML).
2. Describe the natural history of chronic myelogenous leukemia (CML).
3. Identify the clinical signs and symptoms associated with chronic myelogenous leukemia (CML).
4. Discuss treatment options for chronic myelogenous leukemia (CML) with special emphasis on imatinib.
5. Describe the clinical course of chronic lymphocytic leukemia (CLL).
6. Describe patients who may be observed without treatment and those who receive aggressive treatment for chronic lymphocytic leukemia (CLL).
7. Discuss the various treatment options available for chronic lymphocytic leukemia (CLL).
8. Describe the clinical presentation of multiple myeloma.
9. Discuss treatment options available for multiple myeloma.

Faculty:

ACPE No:
014-999-07-108-H04

---

The University of Georgia College of Pharmacy in on probation as an accredited provider of continuing pharmacy education by the Accreditation Council for Pharmacy Education. Next scheduled review for purposes of restoring accreditation or removing accredited provider status: June 2009